Display options
Share it on

Iran Red Crescent Med J. 2015 Dec 05;17(12):e17298. doi: 10.5812/ircmj.17298. eCollection 2015 Dec.

The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus.

Iranian Red Crescent medical journal

Nakisa Rasaei, Mesbah Shams, Eskandar Kamali-Sarvestani, Mohammad Ali Nazarinia

Affiliations

  1. Internal Medicine Ward, Shiraz University of Medical Sciences, Shiraz, IR Iran.
  2. Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran.
  3. Autoimmune Disease Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran.
  4. Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran.

PMID: 26756002 PMCID: PMC4706711 DOI: 10.5812/ircmj.17298

Abstract

BACKGROUND: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease caused by immune system-mediated tissue damage. Autoimmune thyroiditis (AT) is an organ-specific disease associated with production of a variety of antibodies such as antinuclear antibodies, anti-double-stranded DNA, anti-Ro antibodies and anti-cardiolipin antibodies.

OBJECTIVES: The aim of this study was to evaluate the prevalence of thyroid dysfunction and thyroid auto-antibodies in patients with SLE and its relation to SLE disease and other autoantibodies.

PATIENTS AND METHODS: This was a case-control study. The study included a total of 88 patients with SLE and 88 age- and sex-matched healthy volunteers as control group. Two study groups were compared regarding thyroid function test, antinuclear antibody (ANA), antibodies to double-stranded DNA (dsDNA), anti- thyroglobulin antibody (anti-Tg), and anti-thyroid peroxidase (anti-TPO) antibody.

RESULTS: The mean age of SLE patients and controls were 32.16 ± 9.19 and 32.48 ± 9.47 years, respectively (P = 0.821). Patients had significantly higher prevalence (43.2% vs. 23.9%; P = 0.015) and titers (221.8 ± 570.5 vs. 78.2 ± 277.2; P = 0.036) of antibodies to Tg compared to controls. The patients had significantly lower titers of T3 compared to controls (125.2 ± 35.6 vs. 136.2 ± 26.5; P = 0.021). The titers of T4, TSH and anti-TPO antibody did not differ significantly between the two study groups.

CONCLUSIONS: Thyroid dysfunction was not higher in SLE patients compared to healthy individuals. However, anti-Tg antibodies were higher in SLE patients. It has not yet been established that thyroid function tests should be performed routinely in SLE patients.

Keywords: Antithyroid; Lupus Erythematosus Systemic; Thyroiditis Autoimmune Antibodies

References

  1. Arthritis Rheum. 1987 Oct;30(10):1124-31 - PubMed
  2. Ann Rheum Dis. 1986 Jul;45(7):579-83 - PubMed
  3. Rheumatology (Oxford). 2001 Mar;40(3):353-4 - PubMed
  4. Rheumatol Int. 2012 Jan;32(1):73-8 - PubMed
  5. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):107-13 - PubMed
  6. Clin Endocrinol (Oxf). 2015 Dec;83(6):943-50 - PubMed
  7. N Engl J Med. 1994 Jun 30;330(26):1871-9 - PubMed
  8. Scand J Rheumatol. 1995;24(1):13-7 - PubMed
  9. Br J Rheumatol. 1987 Oct;26(5):359-61 - PubMed
  10. Thyroidology. 1993 Apr;5(1):1-7 - PubMed
  11. PLoS One. 2015 Apr 23;10(4):e0123291 - PubMed
  12. Med Princ Pract. 2008;17(1):61-5 - PubMed
  13. Lupus. 1999;8(8):586-95 - PubMed
  14. J Rheumatol. 1991 Aug;18(8):1193-5 - PubMed
  15. Ann Rheum Dis. 2004 Sep;63(9):1159-61 - PubMed
  16. Ann Rheum Dis. 2002 Jan;61(1):70-2 - PubMed
  17. Clin Rheumatol. 2007 Nov;26(11):1891-4 - PubMed
  18. J Clin Endocrinol Metab. 1978 Jun;46(6):859-62 - PubMed
  19. Br J Rheumatol. 1995 Apr;34(4):361-4 - PubMed
  20. J Microbiol Immunol Infect. 2015 Dec;48(6):676-83 - PubMed
  21. Med Clin North Am. 1986 Mar;70(2):337-53 - PubMed
  22. Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68 - PubMed
  23. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):685-708 - PubMed
  24. Clin Rheumatol. 2006 Mar;25(2):240-5 - PubMed
  25. N Engl J Med. 2003 Oct 16;349(16):1526-33 - PubMed
  26. J Clin Rheumatol. 2009 Apr;15(3):117-9 - PubMed
  27. J Clin Lab Immunol. 1990 Jul;32(3):147-51 - PubMed
  28. Pol Merkur Lekarski. 2010 Oct;29(172):231-4 - PubMed
  29. Metabolism. 2010 Jun;59(6):896-900 - PubMed

Publication Types